Korea vs Saudi Arabia: Share of S. aureus infections resistant to methicillin
Korea
45.7%
in 2022
Saudi Arabia
52.0%
in 2022
Korea rank
12th
Saudi Arabia rank
11th
Share of S. aureus infections resistant to methicillin over time
- Korea
- Saudi Arabia
How they compare
Saudi Arabia currently reports 52.0% against 45.7% in Korea, a difference of 6.3%.
That makes Saudi Arabia's figure about 1.1 times Korea's.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was Korea ahead.
Korea ranks 12th and Saudi Arabia ranks 11th of 45 countries.
Across the 2 decades both report, Korea averaged higher in 1 and Saudi Arabia in 1.
Head to head by decade
| Decade | Korea | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 49.7% | 42.8% | 6.8% | Korea |
| 2020s | 46.2% | 67.5% | 21.3% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Korea or Saudi Arabia?
- Saudi Arabia, at 52.0% against 45.7% in Korea as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Korea and Saudi Arabia?
- 6.3%, with Saudi Arabia ahead.
- How many years of comparable data are there for Korea and Saudi Arabia?
- 6 years are reported by both, from 2017 to 2022.
- How do Korea and Saudi Arabia rank globally for share of s. aureus infections resistant to methicillin?
- Korea ranks 12th and Saudi Arabia ranks 11th of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).